Allurion Technologies, Inc. Accrued Marketing Costs, Current
Allurion Technologies, Inc. (ALUR) had Accrued Marketing Costs, Current of $367.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:AccruedMarketingCostsCurrent · last filed 2026-05-15
- 2026-03-31: Accrued Marketing Costs, Current $367.00K.
- 2025-12-31: Accrued Marketing Costs, Current $259.00K.
- 2025-09-30: Accrued Marketing Costs, Current $229.00K.
- 2025-06-30: Accrued Marketing Costs, Current $158.00K.
| Period end | Accrued Marketing Costs, Current |
|---|---|
| 2026-03-31 | $367.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $259.00K 10-Q · filed 2026-05-15 |
| 2025-09-30 | $229.00K 10-Q · filed 2025-11-17 |
| 2025-06-30 | $158.00K 10-Q · filed 2025-08-19 |
| 2025-03-31 | $140.00K 10-Q/A · filed 2025-08-19 |
| 2024-12-31 | $91.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $592.00K 10-Q/A · filed 2025-08-28 |
| 2024-06-30 | $678.00K 10-Q/A · filed 2025-08-28 |
| 2024-03-31 | $845.00K 10-Q/A · filed 2025-08-28 |
| 2023-12-31 | $1.11M 10-K/A · filed 2025-08-28 |
| 2023-09-30 | $2.22M 10-Q · filed 2023-11-14 |
| 2022-12-31 | $481.00K 10-K/A · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |